Keywords: Biology, Models, Methods, Cancer, prostate, metabolomics
Motivation: The progression of prostate cancer is marked by both RB1 and T53 inactivation and higher 18FDG-PET uptake, but it's unclear whether RB1 or TP53 inactivation drives increased glucose import.
Goal(s): Can metabolic changes be used as a biomarker for RB1 and TP53 loss?
Approach: Metabolomic analysis by NMR and IC-MS for a comprehensive measure of metabolic changes ex vivo and and hyperpolarized MRI to measure the Warburg effect in vivo.
Results: 18FDG uptake was unaffected by loss of either RB1 or TP53. RB1 and TP53 did induce a series of other metabolic changes which could be detected in vivo by hyperpolarized MRI
Impact: Neuroendrocrine prostate cancer is a life-threatening progression of prostate cancer that is characterized by mutations in two key genes. Hyperpolarized MRI may enhance early diagnosis of NEPC without biopsy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords